TEMITOPE OLUMUJI: Open Payments
NPI 1760119952 · KATY, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$315 in 7 payments from 5 companies in 2025. Trend: 2023 $2,022 · 2024 $333 · 2025 $315
Food & beverage: $315
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 3 | $174 |
| Teva Pharmaceuticals USA, Inc. | 1 | $84 |
| Alkermes, Inc. | 1 | $22 |
| Almatica Pharma LLC | 1 | $22 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
Products named: REXULTI, AUSTEDO XR, LYBALVI, LOREEV XR, TRINTELLIX.
Industry payments across TX — which companies pay providers there.
